Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 0.11%, near the low end of its 5-year range (0.00%–18.73%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% below its 12-month average of 3.75%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
3.75%
DEBT TO ASSETS RATIO AVG 3Y
0.00%
DEBT TO ASSETS RATIO AVG 5Y
0.11%
DEBT TO ASSETS RATIO AVG 10Y
0.18%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Rein Therapeutics Inc.
Market Cap
$23.06M
Debt to Assets Ratio
0.00%
TTM Avg
3.75%
3Y Avg
0.00%
5Y Avg
0.11%
Market Cap
$23.38M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$22.25M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$22.00M
Debt to Assets Ratio
0.17%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.44M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$25.22M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rein Therapeutics Inc. (RNTX) | $23.06M | 0.00% | 3.75% | 0.00% | 0.11% |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.38M | 0.15% | N/A | N/A | N/A |
| LeonaBio, Inc. (LONA)vs › | $22.68M | 0.01% | N/A | N/A | N/A |
| Modular Medical, Inc. (MODD)vs › | $22.25M | 0.02% | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | 0.17% | N/A | N/A | N/A |
| Kyntra Bio, Inc. (KYNB)vs › | $24.13M | 0.00% | N/A | N/A | N/A |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | 0.00% | N/A | N/A | N/A |
| InspireMD, Inc. (NSPR)vs › | $24.60M | 0.04% | N/A | N/A | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.22M | 0.09% | N/A | N/A | N/A |
| NextCure, Inc. (NXTC)vs › | $20.53M | 0.19% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
4.27
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 18.73% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.05% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.15% |
| 2022-09-30 | 0.25% |
| 2022-06-30 | 0.30% |
| 2022-03-31 | 0.33% |
| 2021-12-31 | 0.33% |
| 2021-09-30 | 0.35% |
| 2021-06-30 | 0.37% |
| 2021-03-31 | 0.93% |
| 2020-12-31 | 2.37% |
| 2020-09-30 | 22.90% |
| 2020-06-30 | 19.93% |
| 2020-03-31 | 24.19% |
| 2019-12-31 | 19.01% |
| 2019-09-30 | 15.12% |
| 2019-06-30 | 13.01% |
| 2019-03-31 | 23.73% |
| 2018-12-31 | 17.62% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
